中国发明与专利（知识产权情报学学报）

在2019年末以来的新冠肺炎疫情中,中医药发挥了自身优势,通过对新冠肺炎的临床辩证和辨病结合进行论治,结合几千年的中医药智慧结晶和当代中医的发展创新,挖掘出一批有积极治疗作用的中药方剂。本文通过总结用于治疗本次新冠肺炎疫情的代表性中药复方,分析目前中医药知识产权的保护形式特点从而得出适合于此次疫情的中药复方的知识产权保护形式,重点阐述了针对代表方"肺炎1号方"的专利申请文件撰写注意事项,并通过连花清瘟等中药名方的国内外企业的相关专利布局分析,给出了"肺炎1号方"的专利技术挖掘建议,以期更好地保护和运用本次抗击新冠肺炎的中医药创新成果。

In the COVID-19 epidemic, traditional Chinese medicine has exerted its own advantages, through clinical dialectics, with thousands of years of wisdom and development and innovation, it has unearthed a group of traditional Chinese medicine prescription with active therapeutic effect. In order to better protect and use the innovation for the prevention and treatment of COVID-19, firstly this article summarizes the representative traditional Chinese medicine compounds for the COVID-19, secondly it analyses the forms of intellectual property protection that can be used for those compounds, thirdly it focuses on the precautions of writing patent application documents for the representative party pneumonia, and then analyzes the related patent layout of traditional Chinese medicine such as Lianhua Qingwen, to give recommendations for the patent technology excavation of the "pneumonia No. 1 prescription".